INTRODUCTION: Epicardial defibrillation systems currently require surgical access. We aimed to develop a percutaneous defibrillation system with partially-insulated epicardial coils to focus electrical energy on the myocardium and prevent or minimize extra-cardiac stimulation. METHODS: We tested 2 prototypes created for percutaneous introduction into the pericardial space via a steerable sheath. This included a partially-insulated defibrillation coil and a defibrillation mesh with a urethane balloon acting as an insulator to the face of the mesh not in contact with the epicardium. The average energy associated with a chance of successful defibrillation 75% of the time (ED75) was calculated for each experiment. RESULTS: Of 16 animal experiments, 3 pig experiments had malfunctioning mesh prototypes such that results were unreliable; these were excluded. Therefore, 13 animal experiments were analyzed - 6 canines (29.8±4.0kg); 7 pigs (41.1±4.4kg). The overall ED75 was 12.8±6.7J (10.9±9.1J for canines; 14.4±3.9J in pigs [P=0.37]). The lowest ED75 obtained in canines was 2.5J while in pigs it was 9.5J. The lowest energy resulting in successful defibrillation was 2J in canines and 5J in pigs. There was no evidence of coronary vessel injury or trauma to extra-pericardial structures. CONCLUSION: Percutaneous, epicardial defibrillation using a partially insulated coil is feasible and appears to be associated with low defibrillation thresholds. Focusing insulation may limit extra-cardiac stimulation and potentially lower energy requirements for efficient defibrillation.

Department of Cardiovascular Diseases Mayo Clinic Rochester MN

Department of Cardiovascular Diseases St Anne's University Hospital Brno Czech Republic

Department of Cardiovascular Surgery Mayo Clinic Rochester MN

Department of Health Science Research Mayo Clinic Jacksonville FL

Department of Pediatrics and Adolescent Medicine Mayo Clinic Rochester MN

Mayo Clinic Ventures Rochester MN

Mayo Medical School Rochester MN

University of Veterinary and Pharmaceutical Sciences Brno Czech Republic

Zobrazit více v PubMed

Lin G, Nishimura RA, Connolly HM, Dearani JA, Sundt TM, 3rd, Hayes DL. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads. Journal of the American College of Cardiology. 2005;45:1672–5. PubMed

Haghjoo M, Nikoo MH, Fazelifar AF, Alizadeh A, Emkanjoo Z, Sadr-Ameli MA. Predictors of venous obstruction following pacemaker or implantable cardioverter-defibrillator implantation: a contrast venographic study on 100 patients admitted for generator change, lead revision, or device upgrade. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2007;9:328–32. PubMed

Sohail MR, Uslan DZ, Khan AH, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. Journal of the American College of Cardiology. 2007;49:1851–9. PubMed

Lee RC, Friedman SE, Kono AT, Greenberg ML, Palac RT. Tricuspid Regurgitation Following Implantation of Endocardial Leads: Incidence and Predictors. Pacing and clinical electrophysiology : PACE. 2015;38:1267–74. PubMed

DeSimone CV, Friedman PA, Noheria A, et al. Stroke or transient ischemic attack in patients with transvenous pacemaker or defibrillator and echocardiographically detected patent foramen ovale. Circulation. 2013;128:1433–41. PubMed

Habib A, Le KY, Baddour LM, et al. Predictors of mortality in patients with cardiovascular implantable electronic device infections. The American journal of cardiology. 2013;111:874–9. PubMed

Novák M, Kamarýt P, Dvořák I, Mach P, Vykypěl T, Müllerová J. ICD lead-related complications. Mid-term follow-up of 172 patients with nonthoracotomy implantation. Cor et Vasa. 2004;46:311–318.

Reddy VY, Exner DV, Cantillon DJ, et al. Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker. The New England journal of medicine. 2015;373:1125–35. PubMed

Bardy GH, Smith WM, Hood MA, et al. An entirely subcutaneous implantable cardioverter-defibrillator. The New England journal of medicine. 2010;363:36–44. PubMed

Lewis GF, Gold MR. Safety and Efficacy of the Subcutaneous Implantable Defibrillator. Journal of the American College of Cardiology. 2016;67:445–54. PubMed

Eberhardt F, Bode F, Bonnemeier H, et al. Long term complications in single and dual chamber pacing are influenced by surgical experience and patient morbidity. Heart. 2005;91:500–6. PubMed PMC

Kubus P, Materna O, Gebauer RA, et al. Permanent epicardial pacing in children: long-term results and factors modifying outcome. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2012;14:509–14. PubMed

Jayam V, Zviman M, Jayanti V, Roguin A, Halperin H, Berger RD. Internal defibrillation with minimal skeletal muscle activation: a new paradigm toward painless defibrillation. Heart rhythm : the official journal of the Heart Rhythm Society. 2005;2:1108–13. PubMed

Jayanti V, Zviman MM, Nazarian S, Halperin HR, Berger RD. Novel electrode design for potentially painless internal defibrillation also allows for successful external defibrillation. Journal of cardiovascular electrophysiology. 2007;18:1095–100. PubMed

Hunter DW, Tandri H, Halperin H, Tung L, Berger RD. Tetanizing prepulse: A novel strategy to mitigate implantable cardioverter-defibrillator shock-related pain. Heart rhythm : the official journal of the Heart Rhythm Society. 2016;13:1142–8. PubMed PMC

Syed FF, DeSimone CV, Ebrille E, et al. Percutaneous Epicardial Pacing Using a Novel Insulated Multi-Electrode Lead. JACC: Clinical Electrophysiology. 2015;1:273–283. PubMed PMC

Sosa E, Scanavacca M, d’Avila A, Pilleggi F. A new technique to perform epicardial mapping in the electrophysiology laboratory. J Cardiovasc Electrophysiol. 1996;7:531–6. PubMed

Gliner BE, Lyster TE, Dillion SM, Bardy GH. Transthoracic defibrillation of swine with monophasic and biphasic waveforms. Circulation. 1995;92:1634–43. PubMed

Haydin S, Saygi M, Ergul Y, et al. Subxiphoid approach to epicardial implantation of implantable cardioverter defibrillators in children. Pacing and clinical electrophysiology : PACE. 2013;36:926–30. PubMed

Jacob S, Lieberman RA. Percutaneous epicardial defibrillation coil implantation: a viable technique to manage refractory defibrillation threshold. Circulation Arrhythmia and electrophysiology. 2010;3:214–7. PubMed

Hsia TY, Bradley SM, LaPage MJ, et al. Novel minimally invasive, intrapericardial implantable cardioverter defibrillator coil system: a useful approach to arrhythmia therapy in children. The Annals of thoracic surgery. 2009;87:1234–8. discussion 1238–9. PubMed

Clark BC, Davis TD, El-Sayed Ahmed MM, et al. Minimally invasive percutaneous pericardial ICD placement in an infant piglet model: Head-to-head comparison with an open surgical thoracotomy approach. Heart rhythm : the official journal of the Heart Rhythm Society. 2016;13:1096–104. PubMed

Prutkin JM, Reynolds MR, Bao H, et al. Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry. Circulation. 2014;130:1037–43. PubMed

Delling FN, Hassan ZK, Piatkowski G, et al. Tricuspid Regurgitation and Mortality in Patients With Transvenous Permanent Pacemaker Leads. The American journal of cardiology. 2016;117:988–92. PubMed PMC

Killu AM, Ebrille E, Asirvatham SJ, et al. Percutaneous epicardial access for mapping and ablation is feasible in patients with prior cardiac surgery, including coronary bypass surgery. Circulation Arrhythmia and electrophysiology. 2015;8:94–101. PubMed

Hsu JC, Marcus GM, Al-Khatib SM, et al. Predictors of an inadequate defibrillation safety margin at ICD implantation: insights from the National Cardiovascular Data Registry. Journal of the American College of Cardiology. 2014;64:256–64. PubMed

Yamada T, McElderry HT, Platonov M, Doppalapudi H, Kay GN. Aspirated air in the pericardial space during epicardial catheterization may elevate the defibrillation threshold. International journal of cardiology. 2009;135:e34–5. PubMed

Thylen I, Dekker RL, Jaarsma T, Stromberg A, Moser DK. Characteristics associated with anxiety, depressive symptoms, and quality-of-life in a large cohort of implantable cardioverter defibrillator recipients. Journal of psychosomatic research. 2014;77:122–7. PubMed

Steinhaus DM, Cardinal DS, Mongeon L, Musley SK, Foley L, Corrigan S. Internal defibrillation: pain perception of low energy shocks. Pacing and clinical electrophysiology : PACE. 2002;25:1090–3. PubMed

Killu AM, Sugrue AM, Mulpuru SK, et al. Trends in percutaneous pericardial access during catheter ablation of ventricular arrhythmias: a single-center experience. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing. 2016;47:109–115. PubMed

Rezq A, Basavarajaiah S, Latib A, et al. Incidence, management, and outcomes of cardiac tamponade during transcatheter aortic valve implantation: a single-center study. JACC Cardiovascular interventions. 2012;5:1264–72. PubMed

Mc AC, Anderson BM, Dimitri W, et al. Long-Term Follow-Up of Isolated Epicardial Left Ventricular Lead Implant Using a Minithoracotomy Approach for Cardiac Resynchronization Therapy. Pacing and clinical electrophysiology : PACE. 2016 PubMed